Creatv Bio, a division of Creatv MicroTech Inc, a liquid biopsy-based cancer diagnostic testing company, announced on Wednesday that it has opened its full service CLIA-certified laboratory in Monmouth Junction, New Jersey.

The new laboratory enables Creatv to provide its LifeTracDx Blood Test, which measures Cancer Associated Macrophage-Like cells (CAMLs) and Circulating Tumor Cells (CTCs), to companies developing and conducting oncology drug trials.

CAMLs have been shown to be detectable in the blood of most cancer patients in all subtypes of malignancies as well as predict treatment response to most therapies within 30-45 days following drug administration.